Previous 10 | Next 10 |
Point Roberts, WA and Delta, BC - December 12, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering cannabis and hemp stocks releases a special report looking at some of the recent developments between the tobacco and CBD/hemp industry, including the rec...
22nd Century Group ( XXII +2% ) closed an investment in Panacea Life Sciences, a developer and producer of legal, THC-free, hemp-derived cannabinoid products. More news on: 22nd Century Group, Inc., Stocks on the move, Read more ...
Williamsville, NY, Dec. 03, 2019 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis plant research, announced today the initial closing of ...
CymaBay Therapeutics (NASDAQ: CBAY ) -75% on halting trial of seladelpar. More news on: CymaBay Therapeutics, Inc., Adamis Pharmaceuticals Corporation, La Jolla Pharmaceutical Company, Stocks on the move, Read more ...
Williamsville, NY, Nov. 21, 2019 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis research, responded today to the FDA’s recent re...
Gainers: Cancer Genetics CGIX +224% . More news on: Surface Oncology, Inc., Cellectar Biosciences, Inc., Magenta Therapeutics, Inc., Stocks on the move, Read more ...
If you're looking to invest in cannabis-focused biotech stocks , there aren't very many choices available. GW Pharmaceuticals (NASDAQ: GWPH) is the biggest alternative based on market cap. 22nd Century Group (NYSEMKT: XXII) is another biotech with an expanding cannabis program. Which o...
Image source: The Motley Fool. 22nd Century Group Inc (NYSEMKT: XXII) Q3 2019 Earnings Call Nov 8, 2019 , 9:00 a.m. ET Operator Continue reading
22nd Century (NYSEMKT: XXII ): Q3 Net operating loss of $7.6M. More news on: 22nd Century Group, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Williamsville, NY, Nov. 04, 2019 (GLOBE NEWSWIRE) -- WILLIAMSVILLE, NY -- 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis plant research, announced...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...